Medication Assisted Treatment Sample Clauses

Medication Assisted Treatment the prescription of medication related to SUD treatment services, or the assessment of the side effects or results of that medication conducted by staff lawfully authorized to provide such services and/or order laboratory testing within their scope of practice or licensure. This means long-acting injectable Vivitrol which is reimbursed for onsite administration and physicians and licensed prescribers in DMC-ODS programs will be reimbursed for the ordering, prescribing, administering, and monitoring.

Medication Assisted Treatment. This shall include dosing of buprenorphine, naloxone, and disulfiram when medically appropriate.

Medication Assisted Treatment. MAT services may be provided onsite with approval for 5 Incidental Medical Services from DHCS. Medically necessary MAT services must be provided in 6 accordance with an individualized treatment plan determined by a licensed physician or LPHA working 7 within their scope of practice. 8 a. MAT services must be provided in compliance with Policy and Procedures submitted to 9 DHCS for IMS designation. CONTRACTOR must ensure ability to continue MAT after discharge 10 through linkage to appropriate prescriber. MAT shall include the assessment, treatment planning, 11 ordering, prescribing, administering, and monitoring of all medications for SUDs. 12 b. CONTRACTOR shall provide administration of buprenorphine, naltrexone (oral and 13 injectable), acamprosate, disulfiram, and vivitrol. Other approved medications in the treatment of SUDs 14 may also be prescribed and administered, as medically necessary. 15 c. CONTRACTOR must provide care coordination with treatment and ancillary service 16 providers and facilitate transitions between levels of care. Beneficiaries may simultaneously participate 17 in MAT services and other ASAM LOCs. 18 d. CONTRACTOR must participate in the ADMINISTRATOR’S Medication Monitoring 19 practices process as a quality assurance measure. Medication Monitoring is to assure the appropriateness 20 of medication prescriptions for Mental Health and Recovery (MHRS) clients and to establish practices for 21 monitoring the safety and effectiveness of medication practices in MHRS.

Medication Assisted Treatment. “MAT”) DISTRIBUTION AND OTHER OPIOID-RELATED TREATMENT 1. Increase distribution of MAT to individuals who are uninsured or whose insurance does not cover the needed service; 2. Provide education to school-based and youth-focused programs that discourage or prevent misuse; 3. Provide MAT education and awareness training to healthcare providers, EMTs, law enforcement, and other first responders; and 4. Provide treatment and recovery support services such as residential and inpatient treatment, intensive outpatient treatment, outpatient therapy or counseling, and recovery housing that allow or integrate medication and with other support services.

Medication Assisted Treatment. Providers will have procedures for linkage/integration for 13 clients requiring medication assisted treatment. Provider staff will regularly communicate with 14 physicians of clients who are prescribed these medications unless the client refuses to consent to sign a 15 42 CFR part 2 compliant release of information for this purpose.

Medication Assisted Treatment the prescription of medication related to SUD 34 treatment services, or the assessment of the side effects or results of that medication conducted by staff 35 lawfully authorized to provide such services and/or order laboratory testing within their scope of 36 practice or licensure. This means long-acting injectable Vivitrol which is reimbursed for onsite 37 // 14 of 22 EXHIBIT A X:\CONTRACTS - 2018 -\2018-2020\SUD\DMC SUD OUTPATIENT SVCS FY 18-20 - LW.DOC «K_CODE»– MADMCOSSUDKK20 1 administration and physicians and licensed prescribers in DMC-ODS programs will be reimbursed for 2 the ordering, prescribing, administering and monitoring.

Medication Assisted Treatment. MAT") DISTRIBUTION AND OTHER OPIOID-RELATED TREATMENT 1. Increase distribution of MAT to individuals who are uninsured or whose insurance does not cover the needed service; 2. Provide education to school-based and youth-focused programs that discourage or prevent misuse; 3. Provide MAT education and awareness training to healthcare providers, EMTs, law enforcement, and other first responders; and 4. Provide treatment and recovery support services such as residential and inpatient treatment, intensive outpatient treatment, outpatient therapy or counseling, and recovery housing that allow or integrate medication and with other support services. 14 As used in this Schedule A, words like "expand," "fund," "provide" or the like shall not indicate a preference for new or existing programs.

Medication Assisted Treatment. ‌ Medication Assisted Treatment (MAT) is widely known for its success in managing and treating opioid use disorders (OUD). MAT is recognized to be an effective strategy by leading public health agencies, such as the World Health Organization and the Centers for Disease Control and Prevention (▇▇▇▇▇▇▇ et al., 2018; World Health Organization, 2009). The uptake, accessibility, and general interest of this medication has grown. Ukraine has been offering MAT since 2004, and Methadone Medication Treatment (MMT) since 2007, though a limited number of individuals seek treatment (Avert, 2017; ▇▇▇▇▇▇▇ et al., 2014). Despite the 340,000 PWID in Ukraine (UNAIDS, 2017), approximately 9,000 were enrolled on MAT in 2017 (Green, 2017). Historically, addiction treatment was limited to mental health facilities or via counseling services (▇▇▇▇▇▇ & ▇▇▇▇▇▇, 2005). Now, however, the Ukrainian government has become increasingly interested in supporting MAT. While treatment has been funded by international donors and agencies, the government decided to fund treatment throughout health care facilities across Ukraine in 2018 ("Ukraine to finance expanded opioid substitution therapy programme", 2018). This expansion of substance use treatment will provide access to treatment for over 10,000 individuals ("Ukraine to finance”, 2018). OAT, a form of MAT, benefits the health of those in recovery in ways other than its purpose to reduce drug use and cravings. On a population scale, the burdensome HIV epidemic could be impacted by the uptake of treatment. Focus-group participants reported that by being on OAT, they are less focused on finding a drug supply and are able to focus on their HIV treatment (▇▇▇▇▇▇▇ et al., 2010). Another study found those who were prescribed OAT more likely to be diagnosed, linked, retained, and in treatment for HIV (▇▇▇▇▇▇▇▇ et al., 2018). Additionally, individuals enrolled on MMT were found to have greater adherence to tuberculosis treatment and for a longer duration of time (▇▇▇▇▇▇▇▇ et al., 2013). Thus, retention to OAT is critical to limit the amount bacterial and viral infections (▇▇▇▇▇▇▇ et al., 2017). Through a mixed-methods study, ▇▇▇▇ et al. (2017) reviewed behaviors of women who inject drugs in Ukraine that were enrolled on OAT in comparison to those not. Those enrolled on OAT reported a lower drug use and cravings. These women also practiced less sexual risk- behaviors, though through qualitative focus groups, researchers learned that sexual drive i...

Medication Assisted Treatment. Psychiatric evaluation, medication management services and care coordination to assist patients in abstaining from alcohol.